Michael Cloonan - Feb 6, 2025 Form 4 Insider Report for Sionna Therapeutics, Inc. (SION)

Role
President & CEO, Director
Signature
/s/ Jennifer Fitzpatrick, Attorney-in-Fact
Stock symbol
SION
Transactions as of
Feb 6, 2025
Transactions value $
$0
Form type
4
Date filed
2/10/2025, 04:05 PM
Previous filing
Oct 2, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SION Stock Option (Right to Buy) Award $0 +450K $0.00 450K Feb 6, 2025 Common Stock 450K $18.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in forty-eight equal monthly installments following February 6, 2025, subject to the Reporting Person's continued service on each such vesting date.